Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
-
Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession License
-
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference
-
Xtract One Announces Fiscal 2024 Third Quarter Conference Call
-
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
-
Planet Fitness’ High School Summer Pass™ Returns; Teens Work Out Free June 1 – August 31
-
G2 Goldfields Files NI 43-101 Technical Report for the Updated Mineral Resource Estimate at the OKO Project in Guyana
-
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
-
West Red Lake Gold Intersects 37.33 g/t Au over 2.79m and 5.26 g/t Au over 9.0m at North Austin Zone – Madsen Mine
-
ECARX-Powered Lynk & Co. 07 EM-P Sedan Began Deliveries in China
-
Orgenesis Provides Business Update for the First Quarter of 2024
-
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease
-
American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024
-
Greenbacker delivers first quarter results
-
Arctic Wolf 2024 Trends Report Reveals 70% of Businesses Targeted by Business Email Compromise (BEC) Attacks
-
CareerCircle Recognized for Shaping the Future of Business by Chief and SIA
-
First Ever: Plum Brings Company Culture, Career Navigation and Deep Talent Insights Together Through New Products
-
BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
-
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
-
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
-
Amplify ETFs Launches The Amplify Weight Loss Drug & Treatment ETF (THNR)
-
Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
-
PyroGenesis Announces Receipt of $1.5 Million as Settlement in Legal Proceedings
-
PlanSource Announces New Retroactive Payroll Module in the Spring 2024 Product Release
-
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
-
KANZHUN LIMITED Announces First Quarter 2024 Financial Results
-
Beyond BookSmart CEO Michael Delman and its Executive Function Coaching Clients to be Featured on ABC’s Good Morning America Series on Boys and Learning
-
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
-
Amplify ETFs Launches The Amplify Weight Loss Drug & Treatment ETF (THNR)
-
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference
-
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
-
Boyden Ranked by Forbes as Top Executive Recruiter
-
ChangeNOW Announces Listing of USDT TON Stablecoin on Its Exchange
-
BLM and DOGAMI Agree to a Joint Reclamation Bond for the Proposed Grassy Mountain Gold and Silver Mine
-
Kincell Bio Announces New Board Chairman Mark R. Bamforth to Accelerate Company’s Growth and Expansion
-
PyroGenesis Announces Receipt of $1.5 Million as Settlement in Legal Proceedings
-
GXO Deploys Innovative Approach to Providing Workforce Flexibility
-
BW Energy: Invitation to Q1 2024 results presentation 24 May
-
ECARX-Powered Lynk & Co. 07 EM-P Sedan Began Deliveries in China
-
CIRRO returns to DELIVER Europe 2024 with enhanced presence and solutions for retail and e-commerce
-
AutoZone 3rd Quarter Total Company Same Store Sales Increase 0.9%; Domestic Same Store Sales were flat; EPS Increases to $36.69
-
YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
-
MAG Silver Announces Planned Retirement of CXO
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - QUANEX BUILDING PRODUCTS - Ordinary Shares
-
Waldencast Reports Q1 2024 Financial Results
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JOHN WOOD GROUP PLC - Ordinary Shares
-
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
BREAKING CEREVEL INVESTIGATION: BFA Law Is Investigating the $45 Per CERE (Nasdaq) Share Offer by AbbVie, Contact the Firm for Details

